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A INTRODUCTION
A1




Surprising variation continues to be found in the
management of individual patients with identical con-
ditions. Variations arise not only from country to
country but often from one hospital to another in the
same city. Widely accepted standards of care and
international consensus statements to facilitate this
process, particularly in less common diseases, are
needed. These statements are also part of the move-
ment toward evidence-based medicine, predeter-
mined health care paths, managed care, and cost-ben-
efit analysis. Such consensus documents help main-
tain international medical standards and are particu-
larly valuable when national health care systems have
evolved along different paths and to different levels.
Consensus statements help promote a uniform high
level of medical care across different countries.
Why should a consensus document make any dif-
ference? Experience has shown that such documents
are increasingly referred to to resolve conflicts in the
medical literature. This is only true if the process
whereby such documents are developed is credible
and if the document is developed by recognised inter-




To be credible and achieve these functions, a consen-
sus process should ideally fulfill the following criteria:
• Objectives must be clearly defined.
• The scope, particularly in terms of the patient pop-
ulation whose management it addresses, must be
clearly set out.
• The methodology and sources of information used
to arrive at its conclusions must be defined, and the
level and breadth of consultation and subsequent
endorsement should be clearly spelled out.
• Existing guidelines should be acknowledged and
discussed.
• Participants, both individuals and societies, must
be described and represent all relevant key disci-
plines. The breadth of consultation should be
described, and minority views should be identified
and represented.
• Potential health benefits, risks, and costs incurred
from the recommended management should be
assessed.
A 1.3
History of the Consensus Process
The current process, concerned with the management
of patients with atherosclerotic arterial occlusive dis-
ease in the legs, arose from the European Consensus on
Critical Leg Ischaemia, which began as a series of inter-
national workshops in 1988 and reached fruition with
the publication of the Second European Consensus at
the end of 199J.1 This work was confined to Europe
because it was believed that the problems inherent in a
multidisciplinary and multinational process made a
wider geographical coverage impractical at that stage.
It was also limited to the more severe stages of
ischaemia, for that was the focus of much controversy
and wider variations in management. There is now a
need for broader clinical and geographical focus,
which has encouraged us to revise and expand it on a
wide trans-Atlantic and societal basis and to include
the management of patients with all degrees of severi-
ty of atherosclerotic disease in the legs.
A 1.4
Objectives of the Document
The objectives of the current document can be sum-
marised as follows:
• Formulate a consensus expert opinion by represen-
tatives from key professional societies involved in
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the management of leg ischaemia and refine that
opinion with frequent input from the societies.
• Evaluate best available evidence and set out appro-
priate management algorithms to achieve the opti-
mal outcome for the patient.
• Standardise classification and terminology.
• Set guidelines for reporting and evaluating clinical
studies, including outcome assessment.
• Encourage a multidisciplinary approach from all
groups skilled in the management of these patients,
including angiologists, vascular physicians, vascu-
lar surgeons, interventional radiologists, haernatol-
ogists, diabetologists, and cardiologists.
• Identify and explore areas of genuine controversy
that need resolution.
A 1.5
Organisation of the Document
To achieve an in-depth consideration of the topic, it
was decided to confine this Consensus document to
peripheral arterial occlusive disease (PAD) because of
atherosclerosis affecting the legs. Ischaemia of the
arms and other peripheral vessels is therefore exclud-
ed, as is occlusive arterial disease due to much rarer
pathological conditions such as Buerger's disease or
vasculitis. However, these other conditions are consid-
ered in the differential diagnosis section. The docu-
ment is confined to symptomatic patients, although
the importance of asymptomatic PAD in terms of car-
diovascular risk is recognised. This is dealt with in
Epidemiology (p 54).
The document itself is divided into four principal
sections: an introduction followed by sections on
intermittent claudication, acute limb ischaemia, and
critical limb ischaemia. For reasons discussed in detail
at the beginning of the section on chronic critical limb
ischaemia (CLI), this term is used to include all
patients with rest pain, gangrene, or ulcers predomi-
nantly due to arterial disease. This was done to ensure
that all patients with significant PAD attributable to
atherosclerosis are considered in one of the sections.
The arguments for and against a more restricted defi-
nition of critical limb ischaemia are also considered at
the beginning of Section D (Critical Limb Ischaemia).
The definitions and classifications of intermittent clau-
dication and acute limb ischaemia are also considered
at the beginning of the Sections C and D, respectively.
The epidemiology of all degrees of severity of PAD
is discussed in a single chapter in the introductory
Section A. In view of the recent rapid evolution and
problems associated with national health care provi-
sions, it was thought necessary to consider in detail
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issues relating to outcome measures of effectiveness
and related socioeconomic issues. The general princi-
ples of these relatively new disciplines are also dis-
cussed in the introductory section, but the application
of these principles is integrated into the clinical chap-
ters of the appropriate parts of Sections B, C, and D.
Outcome assessment methodology and clinical trials
issues are clearly related but in this document are dis-
cussed under separate sections. This is because out-
comes assessment is a more general process that ide-
ally should be practiced in all centers treating patients
with PAD, whereas the chapters on Clinical Trials




The current process began in 1996 with meetings of
the Consensus Working Group, which consisted of
liaison members approved by each participating soci-
ety listed at the front of the document. Three addi-
tional members were chosen for their expertise in
health economy and outcome assessment. The
Consensus Working Group reviewed the literature
and, after extensive correspondence and a series of
meetings, proposed a series of draft documents with
clear recommendations to form the basis of further
consultations. Each participating society set up its
own Advisory Group within the society to review and
comment on these draft consensus documents. The
liaison member from each society then took these
views back to the Consensus Working Group, where
all of the amendments, additions, and alterations sug-
gested by each participating society were discussed at
a further series of meetings, and the final Consensus
Document was agreed on.
The participating societies were then again invited to
review the final document and endorse it if they agreed
with its contents. If an individual participating society
did not accept any specific recommendation, this is
clearly indicated in the final document. Therefore,
except where such specific exclusions are indicated, this
Consensus Document represents the view of all of the
participating societies.
The criteria for a credible consensus process, listed
above, were clearly adhered to. The references in the
document are intended to be comprehensive rather
than exhaustive. Not all of the publications considered
by the participating societies in the Consensus Working
Group are necessarily quoted, but all of the key refer-
ences are included, particularly in the areas of contro-
versy. A deliberate attempt was made to incorporate in
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the final Consensus Document very useful work recent-
ly performed by other, similar groups dealing with
more specific topics. In particular, we relied on the
"Consensus Document on Thrombolysis in the
Management of Leg Ischaemia," "Guidelines for
Peripheral Percutaneous Transluminal Angtoplasty,"
and "Suggested Standards and Reports Dealing with
Lower Extremity Ischemia.T-v' The debt owed to these
and other documents is clearly indicated in the text.
The Consensus Working Group gave serious con-
sideration to using a formal assessment of every clini-
cal study quoted to classify its weight as evidence,
adopting a system similar to that used by the National
Institutes of Health Consensus Development
Conferences, who defined "levels of evidence" and
"grades of recommendation." 5,6 Such a system means
that firm recommendations are based only on the
results of rigorously controlled investigations. The
Working Group rejected such a formal process, princi-
pally because formal proof and studies with high lev-
els of evidence were typically lacking in this area. All
recommendations are based on the best available evi-
dence, and where insufficient evidence exists, critical
issues have been identified. The text and the wording
of recommendations in the Consensus Document
clearly attempt to identify the quality of the evidence
available to support individual recommendations.
A 1.7
Caveat
Any interpretation of the recommendations should be
in the context of the facilities and expertise available in
individual institutions. Often the recommendations
aim at an optimal scenario in the full realisation that
this may not be achievable in many hospitals.
Nevertheless, it was believed that there would be
some purpose in setting out an ideal aim. On other
occasions, the wording of the recommendation makes
clear that a minimum acceptable level is meant.
Irrespective of specific recommendations, all of the
societies participating in this process agree that the
treatment of every patient must of necessity be indi-
vidualised. The physicians involved need to take into
account individual circumstances and influences that
must quite properly override any recommendations in
this document, which of necessity must be generalisa-
tions. We envisage this document forming the basis of
















Fig 1: Consensus methodology.
Eur J Vase Endovasc Surg Vol 19 Supplement A, June 2000
84 Objectives and Methodology of the Consensus Process
Finally, in the course of developing this document,
it became clear that in some key areas no strong opin-
ions are held because of absence of sufficient relevant
hard data. These "Critical Issues" have been identified
as such in the document. Consensus documents such
as this must, of necessity, be ephemeral. The scientific
process was completed in the middle of 1999 and rep-
resents the up-to-date view at that time. It must be
accepted that further evidence will make some of the
conclusions in the document out of date and incorrect
in subsequent years. The participating societies there-
fore commit themselves to continuing the update
process (Figure 1).
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The management of the patient with peripheral arteri-
al disease (PAD) has to be planned in the context of the
epidemiology of the disease and, in particular, the
apparent risk factors or markers predicting sponta-
neous deterioration. It is also necessary to know the
magnitude of the problem together with the likely
outcome in patients with differing severity of PAD to
analyse outcome measures and to assess the socioeco-
nomic impact of the disease. A detailed search of all
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the relevant publications was performed for this chap-
ter. The resulting full analysis of the data has been
published separately in Seminars ill Vascular Surgery.l
A full list of references and complete tables of data
also can be found in that publication. Those tables are
the basis for the summary figures and diagrams repro-




The Problem of Defining Intermittent Claudication
Intermittent claudication (IC) is usually diagnosed by
a history of leg pain on exercise that is relieved by rest.
Several questionnaires have been developed for epi-
demiological use. Other diagnostic methods include
interview, clinical examination, and noninvasive tests.
In looking at methods for identifying IC in the popu-
lation, it must be remembered that it is merely a symp-
tom of PAD and that the measurement of symptoms is
notoriously difficult. A patient with quite severe PAD
may not have the symptom of IC because some other
condition limits exercise. Likewise, patients with very
mild PAD may have symptoms of IC if they are very
active.
Questiollllaires
The WHO/Rose Questionnaire has been the most
widely used cardiovascular questionnaire for the
identification of patients with Ie. It was designed in
1962 by Rose,2 was subsequently adopted by the
WHO, and has been widely used to estimate the preva-
lence of intermittent claudication.s In one survey in a
large population in France, this questionnaire was
shown to be highly specific (99.8%) in excluding
healthy individuals but only moderately sensitive
(67.5%) in detecting those with claudication compared
with physicians' assessments of symptoms (Table 1}.3
In other words, there were only 0.2% false; false posi-
tives are questionnaire-positive individuals who were
not patients with intermittent claudication) but 32.5%
false negatives (false negatives are patients with inter-
mittent claudication who were questionnaire nega-
tive). The classification was extended in 1985 to
include "possible.claudicants" (ie, those patients with
exercise leg pain that is not present at rest, but who are
not otherwise fully concordant with the Rose criteria)
